Cargando…
Case Report: Clinical Analysis of Fulminant Mycoplasma pneumoniae Pneumonia in Children
Fulminant Mycoplasma pneumoniae pneumonia (FMPP) accounts for 0.5–2% of all MPP cases, which is considered as MPP combined with severe complications such as hypoxemia, acute respiratory distress syndrome, or acute respiratory failure. It primarily affects young adults with no underlying disease. Alt...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696182/ https://www.ncbi.nlm.nih.gov/pubmed/34956973 http://dx.doi.org/10.3389/fped.2021.741663 |
_version_ | 1784619750495617024 |
---|---|
author | Zhang, Tongqiang Han, Chunjiao Guo, Wei Ning, Jing Cai, Chunquan Xu, Yongsheng |
author_facet | Zhang, Tongqiang Han, Chunjiao Guo, Wei Ning, Jing Cai, Chunquan Xu, Yongsheng |
author_sort | Zhang, Tongqiang |
collection | PubMed |
description | Fulminant Mycoplasma pneumoniae pneumonia (FMPP) accounts for 0.5–2% of all MPP cases, which is considered as MPP combined with severe complications such as hypoxemia, acute respiratory distress syndrome, or acute respiratory failure. It primarily affects young adults with no underlying disease. Although some studies have proved the severity of FMPP, the details about clinical diagnosis and treatment of FMPP in children have been rarely reported. In this case study, we described three cases who suffered from FMPP. These children not only developed acute lung injury and multiple organ involvement within 7 days of treatment, but were also found plastic bronchitis by bronchoscopy. Finally, all the patients were treated successfully with azithromycin, glucocorticoid, and bronchoscopy lavage. We conclude that this case study would contribute to raise awareness with respect to FMPP, which may occur at a younger age with faster disease progression and common extrapulmonary manifestations. It also reinforces the importance of early identification and prompt intervention to save life of children and reduces sequelae. Further studies are needed about mechanism of FMPP. |
format | Online Article Text |
id | pubmed-8696182 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86961822021-12-24 Case Report: Clinical Analysis of Fulminant Mycoplasma pneumoniae Pneumonia in Children Zhang, Tongqiang Han, Chunjiao Guo, Wei Ning, Jing Cai, Chunquan Xu, Yongsheng Front Pediatr Pediatrics Fulminant Mycoplasma pneumoniae pneumonia (FMPP) accounts for 0.5–2% of all MPP cases, which is considered as MPP combined with severe complications such as hypoxemia, acute respiratory distress syndrome, or acute respiratory failure. It primarily affects young adults with no underlying disease. Although some studies have proved the severity of FMPP, the details about clinical diagnosis and treatment of FMPP in children have been rarely reported. In this case study, we described three cases who suffered from FMPP. These children not only developed acute lung injury and multiple organ involvement within 7 days of treatment, but were also found plastic bronchitis by bronchoscopy. Finally, all the patients were treated successfully with azithromycin, glucocorticoid, and bronchoscopy lavage. We conclude that this case study would contribute to raise awareness with respect to FMPP, which may occur at a younger age with faster disease progression and common extrapulmonary manifestations. It also reinforces the importance of early identification and prompt intervention to save life of children and reduces sequelae. Further studies are needed about mechanism of FMPP. Frontiers Media S.A. 2021-12-09 /pmc/articles/PMC8696182/ /pubmed/34956973 http://dx.doi.org/10.3389/fped.2021.741663 Text en Copyright © 2021 Zhang, Han, Guo, Ning, Cai and Xu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pediatrics Zhang, Tongqiang Han, Chunjiao Guo, Wei Ning, Jing Cai, Chunquan Xu, Yongsheng Case Report: Clinical Analysis of Fulminant Mycoplasma pneumoniae Pneumonia in Children |
title | Case Report: Clinical Analysis of Fulminant Mycoplasma pneumoniae Pneumonia in Children |
title_full | Case Report: Clinical Analysis of Fulminant Mycoplasma pneumoniae Pneumonia in Children |
title_fullStr | Case Report: Clinical Analysis of Fulminant Mycoplasma pneumoniae Pneumonia in Children |
title_full_unstemmed | Case Report: Clinical Analysis of Fulminant Mycoplasma pneumoniae Pneumonia in Children |
title_short | Case Report: Clinical Analysis of Fulminant Mycoplasma pneumoniae Pneumonia in Children |
title_sort | case report: clinical analysis of fulminant mycoplasma pneumoniae pneumonia in children |
topic | Pediatrics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696182/ https://www.ncbi.nlm.nih.gov/pubmed/34956973 http://dx.doi.org/10.3389/fped.2021.741663 |
work_keys_str_mv | AT zhangtongqiang casereportclinicalanalysisoffulminantmycoplasmapneumoniaepneumoniainchildren AT hanchunjiao casereportclinicalanalysisoffulminantmycoplasmapneumoniaepneumoniainchildren AT guowei casereportclinicalanalysisoffulminantmycoplasmapneumoniaepneumoniainchildren AT ningjing casereportclinicalanalysisoffulminantmycoplasmapneumoniaepneumoniainchildren AT caichunquan casereportclinicalanalysisoffulminantmycoplasmapneumoniaepneumoniainchildren AT xuyongsheng casereportclinicalanalysisoffulminantmycoplasmapneumoniaepneumoniainchildren |